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ABSTRACT 
The clinical management of suicidal patients can be 
very challenging. This paper guides the reader through 
the basic steps in assessing a subject and deciding the 
type of treatment to provide. Characteristics of main 
psychiatric pathologies associated with suicidality are 
described, with attention to the peculiarities that spe-
cific associations may frequently entail. 
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1. INTRODUCTION 
Assessing or treating a suicidal patient represents pro- 
bably the most challenging task clinicians have to face in 
their professional life, both intellectually and emotionally. 
Not many clinical interactions generate emotional re-
sponses quite as intense as dealing with an individual who 
has recently survived a serious suicide attempt or is con-
templating a fatal act in the near future. There are multi-
ple reasons behind these responses. Firstly, as clinicians 
we have been trained to objectively and systematically 
assess symptoms and signs of illness in order to reach a 
sound diagnosis. On the basis of this diagnosis—whether 
provisional or confirmed—we have the responsibility of 
formulating and evaluating an effective treatment plan. 
In the case of suicidality, what we are often faced with is 
not a diagnosable illness but a behaviour to which many 
different psychiatric illnesses of various severities may 
contribute. In some cases, no detectable psychiatric ill- 
ness is present. Secondly, as clinicians we have been in- 
vested with the responsibility of ensuring the well being 
of our patients and, as much as possible, to avert compli- 
cations arising from illnesses. In recent times, clinicians 
have experienced an increasing level of scrutiny into the 
validity of the diagnoses attributed to patients and the ef- 
fectiveness of the treatment strategies implemented. The 
threat of litigation has greatly affected the way clinicians 
approach clinical interactions with their patients. As a 
result, being able to manage the countless issues sur-
rounding the assessment and management of individuals 
presenting with suicide risk represents one of the funda- 
mental skills clinicians have to develop and preserve 
throughout their professional life. In this article, we will 
attempt to describe and clarify the most salient aspects of 
dealing with suicidality in every-day clinical practice. 
2. DEFINITIONAL ISSUES 
The first obstacle faced in approaching the suicidal pa- 
tient is certainly how to appropriately define the behav- 
iour we are about to assess. In recent years, there has been 
considerable debate surrounding the validity of current 
definitions, in particular for what relates to our ability to 
differentiate suicidal behaviour from self-harm behaviour 
without suicide intent [1,2]. In this chapter the term “sui- 
cidal” will be used to describe any behaviour or ideation 
involving harm to self irrespective of the level of intent 
to die. The reason for approaching the subject from this 
stance is two-fold. On one hand, as stressed by [3], the 
motives behind self-injurious behaviours and suicidal idea- 
tion are sometimes so difficult to establish that clinicians 
will never be in the position to exclude suicide intent 
unequivocally [4]. The other consideration to be made is 
that despite the many differences observed between indi- 
viduals with self-harm and suicidal behaviour, the ab- 
sence of reported suicidal intent is not sufficient to exclu- 
de the risk of completed suicide. On the contrary, the pre- 
sence of self-injurious behaviour significantly increases 
the risk of suicide later in life. In a recent cohort study of 
individuals presenting to an emergency department fol-
lowing self-harm, the authors found that in the 4-years 
following presentation the rate of completed suicide was 
30 times greater than the one expected in the general 
population [5]. In addition, mental health clinicians should 
be aware of the frequent fluctuations in suicidality indi- 
viduals may manifest, these ranging from death wishes to 
completed suicide, with intervals free from any suicide 
ideation [6,7]. 
3. EPIDEMIOLOGICAL DIMENSION 
Before delving into the clinical aspects of suicide, it is 
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important to make it clear that suicidal behaviour cannot 
be fully understood if interpreted only as a consequence 
of psychiatric illness. In fact, suicidal behaviour is a multi- 
factorial event, extending beyond the psychiatric or psy- 
chopathological realm of human experience. 
The global mortality rate from suicide in 2000 was 
16/100,000, with approximately one million individuals 
taking their life that year. For countries that report mor-
tality data to the World Health Organization (WHO), the 
rate of suicide has increased by 60% over the last 45 
years [8], with suicide being represented in the top ten 
leading causes of death for all ages, but in the top three 
for the age group of 15 - 34 years [8]. Sadly, for every com- 
pleted suicide at least six other people related to the de- 
ceased remain deeply affected [9].  
“Attempted suicides” (non-fatal suicidal behaviours) 
are estimated to be up to 20 times as frequent as suicide 
[6]. Data on the incidence of suicide ideation is unfortu- 
nately not as reliable as we would hope, but we have 
some information regarding the number of people con- 
templating suicide during their lives. In a recent interna- 
tional multi-centre community survey study, up to 25% 
of the interviewees reported having contemplated suicide 
during their life, with up to 15% going as far as planning 
a suicide act. It is also worth considering that in the same 
study, between 0.4% and 4.2% of the people surveyed 
reported at least one suicide attempt during their life [10]. 
4. RISK ASSESSMENT 
Without a doubt, the most important clinical tool psychia- 
trists require in approaching a suicidal patient is the abil- 
ity to conduct an efficient and effective risk assessment. 
In this procedure, the various aspects of patients’ demo- 
graphic data and personal and family history are transla- 
ted into risk or protective factors on the basis of what 
available research data reveal. The ultimate objective of 
the interview is to transform the information gathered 
into a statement that includes the overall level of risk for 
that individual. In doing that, we have to remember that 
the amount and reliability of the information we obtain 
during a risk assessment will be closely related to the 
strength of the therapeutic relationship with the patient 
we are interviewing: the longer the relationship (and the 
therapeutic alliance), the higher the probability of a posi- 
tive impact on the outcomes. 
Before going any further, it is important to understand 
that a risk assessment is in no way a tool we can utilize 
to predict suicide. Unfortunately, even the most compre- 
hensive risk assessment performed will only be useful to 
gauge the level of risk for that particular individual at 
that particular time. In fact, while some risk and protec- 
tive factors do not change over time, many others do, 
with a significant influence on the choices clinicians have 
to make in managing patients. This means that a patient’s 
risk assessment has to be regularly revised and adjourned 
to reflect the developments in the individual’s clinical 
presentation, life circumstances and treatment, if imple-
mented [11]. In recent years, a number of professional 
bodies have published and regularly updated practice 
guidelines for the assessment and management of indivi- 
duals at risk of suicide, such as those produced by the Na- 
tional Institute for Clinical Excellence [12], the Ameri- 
can Psychiatric Association [13], and the American Aca- 
demy of Child and Adolescent Psychiatry [14]. 
5. UNMODIFIABLE RISK FACTORS 
In assessing risk, we soon realize that some of the vari- 
ables we observe during the interview are beyond our 
control. For example, there are a number of demographic 
variables that have a strong correlation with suicide rates. 
One of the most significant is gender. In fact, even though 
women are more likely to be admitted to a hospital fol-
lowing a suicide attempt, men complete suicide in con-
siderably greater numbers, with around three to four men 
completing suicide for every woman [15]. These differ-
ences appear to have been consistent over time and apart 
for very few exceptions, consistent across cultures [15]. 
A number of variables have been hypothesized as linked 
to this discrepancy (the “gender paradox”): men appear 
to choose more lethal methods; they are more likely to 
manifest impulsive behavior, and to abuse substances. 
Moreover, men are much less prone to seeking help if in 
need [7,16]. 
Among demographic data, we also find age as a signi- 
ficant variable needing consideration when assessing risk. 
In fact, suicide rates steadily increase with age, to reach 
the level of 50/100,000 in the male elderly group as rep- 
resented in Figure 1, which refers to the average rate of 
suicide in the world.   
As also noted in the figure, whereas suicide rate for 
women shows a gradual increase with age, men’ suicide 
rate first peaks in middle adulthood, showing a marginal 
decline until the dramatic increase for the 75+ group [17]. 
Marital status is another important factor to be carefully 
examined even if, because of barriers in collecting reli-
able data, it appears to have been researched less than the 
risk factors discussed so far. Despite this, there is suffi- 
cient evidence to suggest a link between relationship 
status and suicidal behaviour. In general, research supports 
a positive association between being single and suicide 
rates. The association appears stronger if we consider di- 
vorce and—especially—separation [18,19]. A study found 
separated men to be about six times more likely to die 
from suicide than their married counterpart [20]. The 
impact of being single or separated on suicide rates is for 
men far greater than for women [18]. It has been sug- 
gested that in women the effect of being single or separa- 
ted is mitigated by the protective role of parenthood,  
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Figure 1. Average suicide rates in the world [17]. 
 
which has been found to be stronger in female subjects 
[21]. Also, women would generally benefit from far 
greater social networks than men, and this would offer 
both support for emotional ventilation and opportunity for 
new relationships [19].  
Beyond demographic characteristics, suicide risk will 
also be affected by the genetic make-up. For example, it 
has been observed that the risk of suicide in individuals 
with family history of suicide is twice bigger than in the 
general population, independently from the presence of 
severe mental illness [22]. Secondly, the improvement of 
genetic modeling has allowed confirming that adopted 
individuals who complete suicide are more likely to have 
a family history of suicide among their biological rela- 
tives. Again, the impact of genetic predisposition was 
independent from psychiatric disorders commonly asso- 
ciated with suicide [23].  
It is beyond the scope of this article to discuss all pos- 
sible risk factors linked to an increased likelihood of sui- 
cide in the individuals we assess and treat (Table 1). Our 
objective is primarily to alert clinicians about the fact 
that suicide risk assessment requires flexibility and con-
stant adaptability in our perspectives during the interview. 
Many different and multifaceted aspects of human expe- 
rience have to be taken into account to carry out a thor-
ough suicide risk assessment; if we do not maintain a 
“wide open angle” in our examination, we run the risk of 
becoming excessively focused on a partial view of the in- 
dividual’s own experience, thus losing our ability to per- 
form a valid evaluation.  
Having considered some of the demographic and bio- 
logical variables impacting on the level of risk, we now 
come to examine probably the most significant group of 
unmodifiable risk factors clinicians cannot afford to ig- 
nore. A history of attempted suicide, suicide ideation or 
even having been hospitalized for a major mental illness  
Table 1. Risk factors associated with increased suicide risk. 
Demographic factors 
Male gender 
Single 
Separated/Divorced 
Widow/er 
Elderly 
Adolescent 
Gay, lesbian (“discovery” time) 
Suicidal thoughts/behaviours 
Suicidal ideation 
Suicidal plan 
Previous suicide attempt 
Severity of previous attempt 
Lethality of suicide plan 
Suicide intent 
Psychiatric hospitalisation/recent discharge 
Mental illness 
Major depressive disorder 
Bipolar affective disorder 
Schizophrenia 
Anorexia nervosa 
Alcohol abuse disorder 
Cluster B personality disorders 
Psychiatric co-morbidity 
Psychological factors 
Hopelessness 
Panic attacks 
Severe anxiety 
Aggression and impulsivity 
Genetic factors 
Family history of mental illness 
Family history of suicide 
Traumatic childhood 
Sexual abuse 
Physical abuse 
Emotional neglect 
Psychosocial factors 
Unemployment 
Public humiliation 
Divorce 
Loss of support 
Stressful life event 
Access to lethal means 
Adapted from De Leo & Krysinska, 2008 [24]. 
 
significantly exposes individuals to an increased risk of 
suicidal behaviour. An overwhelming amount of research 
data confirms the magnitude of the impact those factors 
have on our ability to predict future behaviour. For ex- 
ample, around 5% of individuals who attempted suicide 
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were found to complete suicide within 10 years [25]. Not 
only previous history of suicide attempts should raise the 
level of clinical alert, but also individuals’ past history of 
suicide ideation. [26], in a population of outpatients, 
measured the level of suicide ideation at the time of 
presentation and the severity of the suicide ideation when 
at its worst in the life span. The authors found that past 
suicide ideation was a far better predictor of future sui- 
cide than the level of suicide ideation at the time of as- 
sessment, with odds ratios of 13.85 vs 5.42. More re-
cently, a great deal of attention has also been focused on 
the relationship between hospitalization and suicide risk. 
Dramatic changes have occurred over the last 30 years in 
the way mentally ill individuals are treated, with a sig- 
nificant shift in the emphasis placed on the utilization of 
hospital/inpatient treatment [27]. We need to be mind- 
ful of the fact that several studies have established a clear 
relationship between suicide and certain aspects of hos- 
pital treatment. Firstly, suicide is highest the first few days 
following hospital admission and the first few days fol- 
lowing discharge. Secondly, suicide risk increases along 
with number of admissions to an inpatient facility [28, 
29]. There is much speculation over the reasons for such 
relationships, which are extremely relevant to ‘front line’ 
psychiatrists, often the only clinicians involved in the de- 
cision over whether to admit or discharge an individual 
at risk of suicide. We are used to think that hospital treat- 
ment represents the best way to avert suicide when indi- 
viduals are considered to be at high risk. Unfortunately, 
in many occasions the hospital environment is inadequ- 
ate to appropriately support the suicidal patient, More- 
over, the stigma attached to psychiatric hospitalisation 
often hinders the process of recovery. The result is, in some 
cases, that the suicidal person perceives the prospect of a 
hospital admission as the “last straw”, paradoxically faci- 
litating suicide completion. Actually hospitalisation should 
always be seen as one of the components of a sound and 
well thought out management plan, and not as an easy 
way to prevent suicide or speed up the healing process 
[30]. 
6. MODIFIABLE RISK FACTORS 
Modifiable risk factors are those factors we as clinicians 
can have some impact on. The same way as for the un- 
modifiable risk factors, we will only concentrate on those 
we cannot afford to ignore in any circumstance.  
Needless to say, any form of suicide ideation is re-
garded as clinically important, and as such requiring the 
utmost diligence in assessing the nature and the extent of 
the suicidal thoughts. As mentioned above, individuals 
who present with suicide ideation are more likely to 
complete suicide regardless of the nature and severity of 
the mental illness they suffer from [26]. Very often indi- 
viduals perceive those thoughts as distressing, but be-
cause of the stigma attached to suicidality, they may not 
be as forthcoming as we would hope. That is why a 
careful and tactful exploration of patients’ suicide idea-
tion requires considerable skills and experience, in par-
ticular with specific populations such as the elderly and 
the adolescents. It is important to stress that exploring 
suicide ideation does not to increase patients’ risk of sui-
cide. In fact, frequently patients find comfort in being 
able to discuss their struggle and ventilate their self-de-
structive thoughts. In the evaluation of patients’ level of 
ideation, it is essential to investigate the presence of any 
intent to act on those thoughts and even more any plans 
enabling the patients to perform the act. Moreover, it is 
the clinician’s responsibility to carefully explore the avai- 
lability of lethal means to carry out the suicidal act and 
ensure steps are taken to limit access to them. It cannot 
be stressed enough that the more detailed the suicide plan, 
the higher the risk of suicide. However, it is also impor- 
tant to consider that, in many cases, individuals who 
have a high level of intent may be reluctant to disclose 
any information that could lead to their suicide plans 
being hindered.  
Of all risk factors for suicide that have been consid-
ered so far, researchers have identified mental illness as 
the most significant. Over 90% of individuals completing 
suicideare affected by at least one mental illness, with 
depression as the most commonly reported (at least in 
30% of cases). Substance abuse disorders are also fre- 
quent (17.6%), as well as schizophrenia (14.1%), and 
personality disorders (13.0%) [31]. Lifetime risk of sui- 
cide in psychiatric illnesses such as depression, schizo- 
phrenia and alcohol use disorder is reported to be around 
5% - 15% [31]. It is also important to consider that even 
though a significant number of individuals who die from 
suicide have never had any medical contact, between 
40% and 60% have seen a clinician in the month preced-
ing suicide [32]. Especially in the western world, the 
relationship between suicide risk and mental illness is so 
strong that no prevention strategy would succeed without 
effective treatment of the disorder individuals present 
with [33,34]. 
7. PROTECTIVE FACTORS 
A risk assessment cannot be considered complete until 
both risk and protective factors are carefully evaluated. It 
has been well established how some factors such as re- 
sponsibility to family and children, religiosity and social 
support can have a positive impact on suicide rates [35]. 
A self-report questionnaire, the Reasons for Living Inven- 
tory, has been found useful in clinical practice to docu- 
ment the presence of possible preventive factors [36]. 
Among the protective factors explored by researchers 
over the years, therapeutic alliance is probably one of the 
most relevant to us as clinicians [37]. Regardless the na- 
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ture of the treatment offered, the interview with a suici- 
dal individual requires the psychiatrist to make every pos- 
sible effort to build trust and a sense of co-operation. It is 
only when sufficient mutual respect is established that 
the patient’s experience can be fully explored and a reli- 
able assessment carried out. Empathy is still one of the 
most powerful tools clinicians can utilize in caring for 
suicidal individuals. However, it may be difficult to 
maintain a sufficient level of empathy when our thera- 
peutic efforts are contrasted by the need to ensure the sa- 
fety of our patients [38]. 
8. INTEGRATING THE INFORMATION 
To this date, there is no recognized tool able to reliably 
predict suicide. The only certainty is that all clinicians 
are expected to perform a competent risk assessment, no 
matter what the circumstances leading to the assessment 
are [39]. To facilitate a productive interviewing, we need 
to provide a safe and comfortable environment. In fact, 
where the interview is performed will have a significant 
impact on the outcome. A suitable room should be se- 
lected to ensure that confidential and emotionally sensi- 
tive information could be comfortably disclosed to the 
clinician without the risk of distraction or intimidation. 
As much as possible, the clinician should put in place 
measures to be able to dedicate to the patient the time 
required for the assessment without interruptions (and, 
helas, sometimes this time is well beyond the hour!). In 
preparing for a risk assessment, it is important to ensure 
that the mental and physical state of the patient are com-
patible with the interview that is about to be undertaken.  
Besides information deriving from the interview with 
the suicidal person, itself, a sound risk assessment could 
benefit from the availability of a “collateral” history. Fre- 
quently, it is on the basis of information disclosed by 
partner or spouse, relatives or friends that individuals 
first come to the attention of clinicians. Despite this, just 
as often we fail to seek or acknowledge the invaluable 
information significant others can provide. In fact, on 
many occasions the collateral history we obtain will be 
the only reason for deeming the patient at high risk and 
initiating treatment. Common examples of this case sce-
nario are patients who purposefully conceal their suicide 
intent and plan, or those who are affected by mental ill-
ness so severe that they are unable to divulge their thou- 
ghts and feelings in an understandable way. 
There is yet another important task clinicians have to 
master in modern day practice, which is the one of thor- 
oughly documenting the information gathered. It goes 
without saying how essential it can be for a psychiatrist 
or a mental health service to have sufficient information 
in the clinical file in the case of litigation or scrutiny [40]. 
Moreover, in current times it is most unusual for a pa-
tient presenting to a mental health service to receive 
psychiatric care from a single clinician. Usually, several 
doctors and mental health professionals become involved 
—in different ways and at different stages—in the man-
agement process. As a result of this, each clinicians has 
the added responsibility to communicate as effectively as 
possible the information collated and what has been done 
up to that point to avoid unnecessary delays or omissions. 
9. THE DEPRESSED PATIENT 
Depressive illnesses affect around 5% of the population. 
The risk of completed suicide has been unequivocally 
linked to depression in its various forms [31]. An esti- 
mate of the suicide risk in a population presenting with 
mood disorders compared to the general population was 
20-fold for major depression, 15-fold for bipolar disorder 
and 12-fold for dysthymia [41]. More recent studies have 
confirmed the role of depression as a precursor of suicide, 
especially when protracted and refractory to treatment 
[42]. In the assessment of a depressed individual, hope- 
lessness requires special consideration. Its significance is 
not only related to its diagnostic value but also as the ex- 
pression of emotional turmoil individuals experience, re- 
gardless of the specific illness being treated. In fact, a sig- 
nificant number of studies have confirmed a close rela- 
tionship between the experience of hopelessness and sui- 
cide risk independently of the severity of the illness itself 
[43]. So much so, that the Beck Hopelessness Scale is 
still one of the most commonly used and valued psycho- 
metric tools utilized in clinical practice [44]. As men-
tioned above, suicide risk is significantly high in bipolar 
disorder, where episodes of depression alternate with 
episodes of mania of varying frequency and severity. 
Even though suicidal behaviour can occur during a pe-
riod of mania, the vast majority of completed suicides in 
individuals with bipolar disorder have been found to oc-
cur during a depressive episode [45]. 
10. THE SCHIZOPHRENIC PATIENT 
Schizophrenia is one of the most severe and disruptive 
mental illnesses, affecting around 0.5% - 1% of the po- 
pulation. It is characterised by impairment in perception, 
cognition, and social and occupational functioning. Pa-
tients typically manifest a varying combination of po- 
sitive and negative symptoms requiring ongoing antipsy-
chotic treatment. The lifetime suicide risk for individuals 
with schizophrenia has historically been quoted at around 
10% of affected individuals. [46] have recently chal-
lenged that notion and estimated that risk at about 5%, 
also finding most of the suicides to occur in the period 
following the illness onset. In the case of schizophrenia, 
it is well recognised that the older the patient, the smaller 
the risk of suicide. The rate of suicide in schizophrenia is 
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influenced by some factors that are illness specific. It has 
been found that factors such as motor restlessness fear of 
mental disintegration and poor adherence to treatment 
impact on the rate of suicide just as much as more gen-
eral factors like depressive illness or previous suicide 
attempts [47]. It is also important to stress again how the 
risk of suicide in schizophrenia peaks in the first few 
days following admission to hospital and following dis-
charge. Even though we institute treatment as effectively 
as we can, with the best of intentions, the process of hos- 
pitalisation can be extremely traumatic. In the same way, 
the period after discharge can be particularly difficult, 
especially in terms of adjusting to life with a newly di- 
agnosed illness that carries little prospects of satisfactory 
recovery and strong stigmatization from community mem- 
bers. Monitoring of mental state and compliance en-
hancing strategies are particularly important in this po- 
pulation. 
11. THE SUBSTANCE ABUSER 
Substance abuse (alcohol abuse in particular) represents 
a social phenomenon with significant repercussions on 
people’s physical and mental health. In regard to suicide 
risk, alcohol abuse is considered second only to depress- 
sion as a precursor to completed suicide [48]. The life- 
time risk of suicide in alcoholics varies considerably 
depending on the reporting habits and the overall rate of 
suicideof the country involved, but it is estimated to be 
around 3% [49]. Most attempted and completed suicides 
in alcoholics appear to be related to a depressive episode, 
stressful live event, loss of support or disruption of inter- 
personal relationships [50]. The impact substances have 
on patients’ level of rationality and impulsivity makes the 
assessment of suicide risk all but secondary in the man- 
agement of substance abuse. 
12. THE PERSONALITY DISORDERED 
PATIENT 
Personality disorders are defined as enduring, inflexible 
and pervasive patterns of behaviour and inner experience 
that seriously deviate from cultural norms and cause sig- 
nificant distress or impairment in various areas of indi-
viduals’ functioning [13]. Of the various personality dis- 
orders known in clinical practice, the most frequently 
encountered in most settings is certainly Borderline Per-
sonality Disorder, which features suicidality and self-in- 
jurious behaviour as essential criteria of illness. Indivi- 
duals affected by one or more personality disorders at- 
tempt and complete suicide just as much as individuals 
diagnosed with a depressive illness [51]. In fact, a review 
of psychological autopsy studies revealed that around 
57% of individuals who had completed suicide had a 
diagnosis of personality disorder [52]. Moreover, perso- 
nality disorders have been found to represent the second 
most common diagnosis after adjustment disorder in a po- 
pulation of suicide attempters [53]. The difficulty in fully 
appreciating the impact personality disorders have on 
suicidality is the fact that they very often coexist with 
other mental illnesses [54]. Moreover, the presence of one 
or more personality disorders represents a significant chal- 
lenge for clinicians and mental health services, both be- 
cause of the disruptive behaviours they often manifest and 
because of the permanent nature of the disorder. 
13. THE ANXIOUS PATIENT 
Anxiety disorders represent the most common group of 
mental illnesses in the community, with almost 30% of 
the population affected by at least one of these disorders 
at some point in their life [55]. Even though trait anxiety 
is often reported as one of the factors increasing suicide 
risk, anxiety disorders have never been seen as indepen- 
dent risk factors for completed suicide. However, a re- 
cent review found that some anxiety disorders may in- 
crease suicide risk, especially when associated with other 
mental illnesses such as depression, bipolar disorder, or 
schizophrenia [56]. In view of this, it is essential to make 
every possible effort to treat any anxiety disorder indi- 
viduals present with, also considering that their response 
to psychiatric interventions is often much better than for 
other mental illnesses. 
14. THE ADOLESCENT PATIENT 
Completed suicide represents the third leading causes of 
mortality in the adolescent population [8] Just under 15% 
will self harm and up to 45% report suicidal ideation dur-
ing their life [47]. More than the adult population, ado- 
lescents are vulnerable to the effects of relationship break- 
down, and physical, sexual and emotional abuse [57,58]. 
Most studies highlight how adolescents who attempt sui- 
cide show reduced distress tolerance skills and poor mood 
regulation [14]. Moreover, adolescents manifest higher 
levels of impulsivity and aggression compared to their 
adult counterpart with a significant impact on the likely- 
hood of self-destructive behaviours [59]. In an attempt to 
facilitate the assessment and treatment of adolescents 
presenting with suicidal behaviour [14] have developed 
practice guidelines to support clinicians in their effort to 
reduce the likelihood of completed suicide in this very 
vulnerable population. 
15. THE ELDERLY PATIENT 
The elderly population is probably the one presenting with 
the most challenges for mental health clinicians [60]. As 
already highlighted, men over 75 years of age carry the 
highest suicide rate of all, and have done that consis- 
tently for a long time. At the same time, the elderly po- 
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pulation will be the most likely to have been seen by a 
medical practitioner in the month preceding their com- 
pleted suicide. A number of factors make detection and 
management of suicide risk extremely difficult [61]. The 
most significant risk factors for suicidal behaviour iden- 
tified in the elderly population are in fact factors such as 
physical illness, social isolation, relationship problems, 
and bereavement or loss [62]. As one can appreciate, it 
would be extremely difficult to identify at risk individu- 
als on the basis of almost universal problems present in 
this population, like those listed above [63]. 
16. TREATMENT 
If the assessment of suicide risk can be perceived at 
times as challenging and overwhelming, the treatment of 
individuals at risk of suicide represents for clinicians a 
real test of psychological strength. In fact, managing sui- 
cidal individuals is often emotionally taxing to the point 
of deterring some clinicians from accepting referrals in- 
volving suicide risk. Unlike other medical disciplines, 
death is not generally acknowledged as a possible com- 
plication of illness in mental health. To cope with the 
increased sense of pressure, mental health clinicians of-
ten become vulnerable to counter-transference reactions 
that instead of facilitating treatment progress create more 
angst and anxiety. Rescue fantasies and attempts to re- 
parent patients are only examples of the many forms 
counter-transference can take [64]. Effective anxiety ma- 
nagement and consistent supervision are imperative for 
any clinician intending to venture into this treacherous 
field of medicine. 
16.1. The Setting 
The management of suicide risk includes a vast number 
of both biological and psychosocial approaches that can 
be utilised at different stages of the treatment process. 
However, the first important decision to be made is the 
selection of the setting in which the patient is going to 
receive the treatment. It is often difficult to ensure the 
safety of the patient, whilst at the same time minimising 
disruption to their already arduous lives [65]. Without a 
doubt, inpatient treatment allows clinicians the constant 
monitoring of suicide risk, mental state and response to 
treatment, and most important of all, visual observation 
of the patient at all times. However, clinicians soon real- 
ise that it is unrealistic, and in some cases unreasonable, 
to rely on segregation as a cure for suicide risk. Often 
suicide risk is increased by financial, interpersonal and 
occupational stressors, and removing individuals from 
their familiar environment can only add to the stress they 
experience in trying to address the difficulties at hand. 
Furthermore, every time we admit a patient to hospital 
and increase the level of supervision by clinical staff, at 
the same time we also cause the suicidal individual to 
lose significant support they would otherwise get in the 
community. In fact, a significant protective factor for 
suicide is interpersonal connectedness, particularly for 
women with children, which we invariably disrupt when- 
ever we opt for inpatient treatment. As a result, hospital 
treatment should be thought of as one of the possible 
options available, and not as a quick fix to the problem 
of suicide risk. Every possible attempt should be made in 
trying to implement treatments that acknowledge the 
strengths individuals possess and maximise the effect of 
protective factors present in patients’ environment. Also, 
when balancing pros and cons of a possible psychiatric 
admission, we need to remember that especially in the 
case of affective and psychotic disorders, the week after 
hospitalisation and the week following discharge is when 
suicide risk is at the highest level [29].  
It is imperative, then, to ensure that the management 
of suicide risk and the treatment of any underlying men- 
tal illness occur within the individuals’ social context 
and family environment in order to promote resilience 
and take advantage of the support already available in the 
community [66]. If hospitalisation is identified as the 
most appropriate course of action, it is important to make 
sure that the patient and his/her carers participate in the 
decision-making process and are aware of the objectives 
clinicians are trying to achieve. It is also fundamental to 
establish an appropriate level of monitoring during the 
inpatient stay to reflect the intensity of suicide risk at the 
different stages of treatment. Standard safety precautions 
should be always implemented to identify and remove 
from the patient and the hospital environment anything 
that can be used to self-harm or attempt suicide. As al- 
ready highlighted, in applying these strategies we must 
always ensure individuals are treated with the least re- 
strictive means. On rare occasions, the level of suicide 
risk and/or the level of uncooperativeness the patient 
displays will be so high that involuntary inpatient treat- 
ment becomes the only viable option. In those occasions 
we have to accept a potential strain to the therapeutic alli- 
ance in order to ensure the safety of the patient. The rea- 
sons for enforcing hospital treatment and not using other 
treatment options should be documented, and a clear treat- 
ment plan should be outlined so that the involuntary 
status is not unduly prolonged. Clinicians should remem- 
ber that if the patient is determined to die by suicide, no 
much can be done to avert it. In a review of inpatient sui- 
cides, it was found that majority of the 76 suicides stud- 
ied were on close observation or even with staff mem- 
bers at the time of suicide [67]. 
If the decision is made that the patient can be safely 
treated as an outpatient, the clinician’s focus will need to 
shift towards maximising the beneficial effect of all the 
protective factors identified during the assessment. Clini- 
Copyright © 2012 SciRes.                                                                       OPEN ACCESS 
A. De Gioannis et al. / Open Journal of Psychiatry 2 (2012) 49-60 56 
cians also need to be mindful of the fact that the stronger 
the therapeutic alliance with the patient is, the higher the 
chances of reducing suicidality will be. Flexibility in the 
delivery of outpatient services is required in addressing 
such difficult circumstances, and clinicians have to be 
ready to increase the frequency of appointments, as well 
as instituting planned telephone contacts between consul- 
tations. Medication should also be reviewed, and appro- 
priate steps should be takensuch as: monitoring and en- 
suring compliance, adding or increasing the dosage of 
certain medications to counteract the impact of possible 
distressing symptoms, and restricting access to large am- 
ounts of medication to reduce patient’s access to means 
of suicide or self harm. In regard to the latter, every pos- 
sible effort should be made—with the cooperation of 
family and carers—to remove all potential means of sui- 
cidefrom the patient’s environment. 
16.2. Psychological Approaches 
Psychotherapies represent a valuable tool in the treat- 
ment and management of suicide risk. Even though none 
of the current approaches utilised in clinical practice has 
been identified as “the approach” able to prevent suicide, 
many of them have been found to significantly contribute 
to the reduction of suicide and self harm risk. The task of 
researching the efficacy of psychotherapy in suicide pre- 
vention is often made arduous by the ethical restrictions 
imposed on the study of individuals at risk of suicide. 
Another difficulty in studying different types of psycho- 
therapeutic approaches is that of ensuring absolute ad- 
herence to the model of treatment by therapists involved 
in the research process. In fact, the impact of factors such 
as the warmth of the therapeutic relationship can signifi- 
cantly impact on outcomes of a given psychotherapeutic 
approach. Despite the above limitations, research in the 
field has produced some useful data that we can transfer 
into every day clinical practice.   
Structured problem-solving, for example, is one mode 
of intervention that has been found useful in the man- 
agement of deliberate self-ham. Even tough studies con- 
ducted so far have provided conflicting evidence regard- 
ing its impact on repetition of DSH, there are promising 
data regarding the impact of such approach on several of 
the risk factors for deliberate self-harm. A meta-analysis 
of randomized controlled trials showed that offering indi- 
viduals with a recent episode of deliberate self harm a 
course of problem solving training not only increased 
individuals’ ability to reduce the impact of stressors, but 
also resulted in a reduction in levels of hopelessness and 
depression [68]. When it comes to more complex modes 
of intervention requiring clinicians to undergo more in-
tensive training and supervision, research into cognitive 
therapy and interpersonal therapy has also produced pro- 
mising results, especially in regard to retention and com- 
pliance with treatment [69,70].  
In the case of individuals presenting with Borderline 
Personality Disorder (where psychological treatment is 
still recognized as the mainstay of any management plan), 
dialectical behaviour therapy (DBT) has been shown to 
produce significant reduction in the rate of repetition of 
deliberate self-harm, suicide ideation and hospitalize- 
tions [71]. Research on the treatment of individuals with 
Borderline Personality Disorder has recently produced 
interesting data on novel approaches, such as mentaliza- 
tion-based treatment with reduction in both suicidality 
and mental health services utilization [72].  
Despite growing interest and research into the psycho- 
social treatment of suicidal behaviour, we are still a long 
way from being able to develop an effective and user- 
friendly approach that can reliably and consistently re- 
duce suicidality in individuals at risk. In fact, larger and 
better-controlled trials are needed in order to produce reli- 
able data we can confidently implement in clinical prac- 
tice [73]. 
16.3. Biological Approaches 
Notwithstanding the multitude of pharmacological agents 
currently available to clinicians, lithium is still the medi-
cation with the most evidence on its efficacy in the 
treatment of suicidality. When administered for the main- 
tenance treatment of bipolar affective disorder, data show 
a suicide rate around eight times lower than in individu- 
als whose treatment did not include lithium. It has also 
been observed that the beneficial impact on suicidality is 
not necessarily related to the mood stabilizing effect 
lithium has on bipolar patients [74]. More recently, evi- 
dence has emerged to support the use of lithium also in 
the treatment of depressive illness regardless of the pre- 
sence of bipolar disorder. In a meta-analysis, the authors 
found that in individuals with recurrent major depressive 
disorder treated with lithium, the reduction in suicide rate 
was very close to the one observed in the bipolar popula- 
tion [75]. The risk of significant side effects and toxicity 
has so far been the main barrier hindering a more wide- 
spread use of lithium as a standard treatment of suicidal- 
ity, especially when prescribed for women in child-bear- 
ing age. As a result, it has been observed that despite the 
overwhelming evidence produced over the years, there 
has been a progressive reduction in the prescription of 
such compounds [76].  
A similar scenario is observed in the case of clozapine, 
an antipsychotic used for the treatment of schizophrenia, 
the beneficial effect of which on suicidality has been es- 
tablished in a number of high quality studies. One of the 
most cited is the InterSePT study, a multicentre, rando- 
mized, international study in which the authors followed 
up for two years 980 patients with schizophrenia or schi- 
zoaffective disorder at high suicide risk. Patients treated 
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with clozapine were found to have a lower rate of suicide 
attempts and hospitalisations, and were less likely to re- 
quire additional medication such as antidepressants or 
anxiolytics [77]. Moreover, it has been demonstrated that 
the reduction in suicide rates for schizophrenia patients is 
independent from the action on the psychotic symptoms 
individuals presented with [35]. However, as observed in 
the case of lithium treatment, the risk of potentially lethal 
adverse events with clozapine treatment has hindered a 
wider utilisation of this very effective agent. The risk of 
neutropenia and cardiotoxicity has in fact made it neces-
sary to enforce very strict protocols of administration and 
monitoring. The end result—in many countries around 
the world—has been that clozapine can only be pre-
scribed as second or third line of treatment by specialised 
clinical centres [78]. 
Electroconvulsive therapy (ECT) is another treatment 
modality often used to reduce suicidality in individuals 
affected by either psychotic or mood disorders. It is par- 
ticularly valuable when other treatments have failed or 
when the use of psychotropic medication is contraindi- 
cated, such as in the case of pregnant women or certain 
medical conditions. It is of note that the impact ECT has 
on suicidality is particularly rapid. In fact, a study by 
[79] on 131 individuals presenting with suicide ideation, 
showed that by week 2 (after 6 ECT sessions) almost two 
thirds of the patients reported a significant reduction in 
suicidality. 
The role of antidepressants medication treatment in 
the prevention of suicide appears to be even more com-
plex. Much research has been produced to try to eluci-
date whether the more widespread use of compounds 
such as the SSRI’s (selective serotonin re-uptake inhibi-
tors) had any clear impact on suicidal behaviour. The 
controversy culminated in 2004, when in the US the 
Food and Drug Administration made a request to drug 
manufacturing companies to include a black-box warn-
ing of increased risk of suicide for children and adoles-
cent with major depressive disorders and other psychiat-
ric disorders. The following year, the same recommenda-
tion was made for SSRI medication prescribed to the 
adult population [80]. In particular, the recommendation 
was to closely monitor patient commenced on SSRI’s in 
the first few weeks of treatment to assess the emergence 
of increased suicidality. Since then, there have been nu-
merous attempts to verify the validity of such warning. A 
number of meta-analyses have been conducted focusing 
on the occurrence of suicidal behaviour in individuals 
treated with SSRI’s. Many of them report a link even if 
not strong, between the use of SSRI’s and suicidal be-
haviour in children and the adolescent population [81,82]. 
In the studies considering the adult population the find-
ings are even less clear. A study focusing on the impact 
of the wider use of antidepressants in Northern Europe 
during the 90’s, found that in many of the countries re-
searched the suicide rate was already declining at the 
time of the introduction of SSRI’s [83,84]. In a meta- 
analysis conducted utilizing drug company data on 40,000 
individuals in 477 randomised controlled trials, the au-
thors found no link between SSRI’s use and suicide rates. 
In the same study, some evidence was found for an in-
creased incidence of non-fatal suicidal behaviour during 
treatment [85].  
17. CONCLUSION 
Dealing with suicidal patients represents a challenging 
clinical task, which requires competence and dedication. 
Apart from knowledge of protocols and therapeutic tools, 
clinicians are particularly requested to care. Being per- 
ceived by the suicidal patient as an insufficiently caring 
professional might constitute the last ring of a long chain 
of disappointments. 
 
REFERENCES 
[1] De-Leo, D., Burgis, S., Bertolote, J.M., Kerkhof, A.J.F.M. 
and Bille-Brahe, U. (2006) Definitions of suicidal be- 
haviour: Lessons learned from the WHO/EURO multi- 
centre study. Crisis, 27, 4-15. 
doi:10.1027/0227-5910.27.1.4 
[2] Silverman, M.M., Berman, A.L., Sanddal, N.D., O’Car- 
roll, P.W. and Joiner, T.E. (2007) Rebuilding the tower of 
babel: A revised nomenclature for the study of suicide 
and suicide-related behaviours. Suicide and Life-Threat-
ening Behavior, 37, 264-277.  
doi:10.1521/suli.2007.37.3.248 
[3] Hawton K. and van Heeringen K. (2002) The Interna-
tional Handbook of Suicide and Attempted Suicide. Wiley, 
Chichester. 
[4] De-Leo, D. (2011) DSM-V and the future of suicidology. 
Crisis, 32, 233-239. doi:10.1027/0227-5910/a000128 
[5] Cooper, J., Kapur, N., Webb, R., Lawlor, M., et al. (2005) 
Suicide after deliberate self-harm: A 4-year cohort study. 
American Journal of Psychiatry, 162, 297-303. 
doi:10.1176/appi.ajp.162.2.297 
[6] De-Leo, D., Cerin E., Spathonis, K. and Burgis, S. (2005) 
Lifetime risk of suicide ideation and attempts in an Aus-
tralian community: Prevalence, suicidal process, and help- 
seeking behaviour. Journal of Affective Disorders, 86, 
215-225. doi:10.1016/j.jad.2005.02.001 
[7] Milner, A. and De-Leo, D. (2010) Who seeks treatment 
where? Suicidal behaviors and health care: Evidence from 
a community survey. Journal of Nervous and Mental 
Disease, 198, 412-419. 
doi:10.1097/NMD.0b013e3181e07905 
[8] World Health Organization (2005) Suicide huge but pre-
ventable public health problem.  
http://www.who.int/mediacentre/news/releases/2004/pr61
/en/ 
[9] Diekstra, R.F.W., Gulbinat, W., Kienhorst, I. and De-Leo, 
Copyright © 2012 SciRes.                                                                       OPEN ACCESS 
A. De Gioannis et al. / Open Journal of Psychiatry 2 (2012) 49-60 58 
D. (1995) Preventive Strategies on Suicide. Vol. 2. Co- 
publication WHO, Geneva & E.J. Brill, Leiden/New 
York/Koln. 
[10] Bertolote, J.M., Fleischmann, A., De-Leo, D., Bolhari, J., 
Botega, N., De Silva, E., Huong, T.T.T., Phillips, M., 
Schlebusch, L., Varnik, A., Vijayakumar, L. and Wasser- 
man, D. (2005) Suicide attempts, plans, and ideation in 
culturally diverse sites: The WHO SUPRE-MISS com-
munity survey. Psychological Medicine, 35, 1457-1465. 
doi:10.1017/S0033291705005404 
[11] American Psychiatric Association (2003) Practice guide-
lines for the assessment and treatment of suicidal behav-
iour. American Journal of Psychiatry, 160, 1-60. 
[12] National Institute for Clinical Excellence (2004) Self- 
harm: The short-term physical and psychological mana- 
gement and secondary prevention of self-harm in primary 
and secondary care. National Institute for Clinical Excel- 
lence, London.  
[13] American Psychiatric Association (2000) Diagnostic and 
statistical manual of mental disorders, 4th Edition TR. 
American Psychiatric Association, Washington, DC. 
[14] American Academy of Child and Adolescent Psychiatry 
(2001) Summary of the practice parameters for the as-
sessment and treatment of children and adolescents with 
suicidal behaviours. Journal of the American Academy of 
Child and Adolescent Psychiatry, 40, 495-499. 
doi:10.1097/00004583-200104000-00024 
[15] De-Leo, D., Bertolote, J.M. and Lester, D. (2002) Self 
directed violence. In: Krug, E.G., Dahlberg, L.L., Mercy, 
J.A., et al. Eds., World Report on Violence and Health, 
World Health Organisation, Geneva, 185-212. 
[16] Brent, D.A. and Mortiz, G. (1996) Developmental path-
ways to adolescent suicide. In: Cichetti, D. and Toth, S., 
Eds., Adolescents: Opportunities and challenges. Univer-
sity of Rochester Press Rochester, New York. 
[17] World Health Organization (2002) Distribution of suicide 
rates (per 100,000) by gender and age, 2000.  
http://www.who.int/mental_health/prevention/suicide/sui
cide_rates_chart/en/  
[18] Wyder, M., Ward, P. and De-Leo, D. (2009) Separation 
as a suicide risk factor. Journal of Affective Disorders, 
116, 208-213. doi:10.1016/j.jad.2008.11.007 
[19] Kolves, K., Ide, N. and De-Leo, D. (2011) Marital break-
down, shame and suicidality in men: A direct link? Sui-
cide and Life-Threatening Behavior, 41, 149-159. 
doi:10.1111/j.1943-278X.2011.00021.x 
[20] Cantor, C.H. and Slater P.J. (1995) Marital breakdown, 
parenthood and suicide. Journal of Family Studies, 1, 91- 
102. doi:10.5172/jfs.1.2.91 
[21] Qin, P., Agerbo, E. and Mortensen, P.B. (2002) Suicide 
risk in relation to socioeconomic, demographic, psychiat-
ric, and familial factors: A national register-based study 
of all suicides in Denmark, 1981-1997. American Journal 
of Psychiatry, 160, 765-772. 
doi:10.1176/appi.ajp.160.4.765 
[22] Runeson, B. and Asberg, M. (2003) Family history of 
suicide among suicide victims. American Journal of Psy-
chiatry, 160, 1525-1526. 
doi:10.1176/appi.ajp.160.8.1525 
[23] Roy, A. (2006) Family history of suicide and impulsivity. 
Archives of Suicide Research, 10, 347-352. 
doi:10.1080/13811110600790983 
[24] De-Leo, D. and Krysynska, K. (2008) Suicide and self- 
directed violence. In: Heggenhougen, K. and Quah, S., 
Eds., International Encyclopedia of Public Health, Aca-
demic Press, San Diego, 267-275. 
[25] Gibb, S.J., Beautrais, A.L. and Fergusson, D.M. (2005) 
Mortality and further suicidal behaviour after an index 
suicide attempt: A 10-year study. Australian and New 
Zealand Journal of Psychiatry, 39, 95-100. 
doi:10.1080/j.1440-1614.2005.01514.x 
[26] Beck, A.T., Brown, G.K., Steer, R.A., Dahlsgaard, K.K. 
and Ggrisham, J.R. (1999) Suicide ideation at its worst 
point: A predictor of eventual suicide in psychiatric out-
patients. Suicide & Life-Threatening Behavior, 29, 1-9. 
[27] Johannessen, H.A., Dieserud, G., Jakhelln, F., Zahl, P.H. 
and De-Leo, D. (2009) Changes in institutional psychiat-
ric care and suicidal behaviour: A follow-up study of in-
patient suicide attempters in Baerum, Norway. Social Psy- 
chiatry and Psychiatric Epidemiology, 44, 845-851.  
doi:10.1007/s00127-009-0006-8  
[28] Hoyer, E.H., Olesen, A.V. and Mortensen, P.B. (2004) 
Suicide risk in patients hospitalised because of an affec-
tive disorder: A follow-up study, 1973-1993. Journal of 
Affective Disorders, 78, 209-217. 
doi:10.1016/S0165-0327(02)00311-7 
[29] Qin, P. and Nordentoft, M. (2005) Suicide risk in relation 
to psychiatric hospitalization. Archives of General Psy-
chiatry, 62, 427-432. doi:10.1001/archpsyc.62.4.427 
[30] De-Leo, D. and Heller, T. (2007) Intensive case man-
agement in suicide attempters following discharge from 
inpatient psychiatric care. Australian Journal of Primary 
Health, 13, 49-59. doi:10.1071/PY07038 
[31] Wasserman, D. (2001) Suicide. An Unnecessary Death, 
Dunitz, London. 
[32] World Health Organization (2000) Preventing Suicide: A 
resource for general physicians. WHO, Geneva. 
[33] Bertolote, J.M., Fleischmann, A., De-Leo, D. and Was- 
serman, D. (2003) Suicide and mental disorders: Do we 
know enough? (Editorial) British Journal of Psychiatry, 
183, 382-383. doi:10.1192/bjp.183.5.382 
[34] De-Leo, D. (2009) Cross-cultural research widens suicide 
prevention horizons (Editorial). Crisis, 30, 59-62. 
doi:10.1027/0227-5910.30.2.59 
[35] De-Leo, D. and Spathononis, K. (2003) Do psychophar-
macological and psychosocial treatments reduce suicide 
risk in schizophrenia and schizophrenia spectrum disor-
ders? Archives of Suicide Research, 7, 354-373. 
doi:10.1080/713848945 
[36] Linehan, M.M., Goodstein, J.L., Nielsen, S.L., et al. (1983) 
Reasons for staying alive when you are thinking of killing 
yourself: The rasons for living inventory. Journal of 
Consulting and Clinical Psychology, 51, 276-286. 
doi:10.1037/0022-006X.51.2.276 
[37] Hendin, H., Haas, A.P. and Maltsberger, J.T. (2006) 
Copyright © 2012 SciRes.                                                                       OPEN ACCESS 
A. De Gioannis et al. / Open Journal of Psychiatry 2 (2012) 49-60 59
Problems in psychotherapy with suicidal patients. Ame- 
rican Journal of Psychiatry, 163, 67-72. 
doi:10.1176/appi.ajp.163.1.67 
[38] Jacobs, D. (1989) Psychotherapy with suicidal patients: 
The empathic method. In: Jacobs, D., Brown, H.N. Eds., 
Suicide: Understanding and Responding. International 
Universities, Madison, 329-342. 
[39] Simon R.I. (2002) Suicide risk assessment: What is the 
standard of care? Journal of the American Academy of 
Psychiatry and Law, 30, 340-344. 
[40] Simon, R.I. (2004) Assessing and Managing Suicide Risk: 
Guidelines for Clinical Risk Management. American Psy- 
chiatric Publishing, Arlington.  
[41] Harris, C.E. and Barraclough B. (1997) Suicide as an out- 
come for mental disorders. British Journal of Psychiatry, 
170, 205-228. doi:10.1192/bjp.170.3.205 
[42] Oquendo, M.A., Currier, D. and Mann, J.J. (2006) Pro-
spective studies of suicidal behavior in major depressive 
and bipolar disorders: What is the evidence for predictive 
risk factors? Acta Psychiatrica Scandinavica, 114, 151- 
158. doi:10.1111/j.1600-0447.2006.00829.x 
[43] Smith, J.M., Alloy, L.B. and Abramson, L.Y. (2006) 
Cognitive vulnerability to depression, rumination, hope-
lessness, and suicidal ideation: multiple pathways to self- 
injurious thinking. Suicide and Life Threatening Behavior, 
36, 443-454. doi:10.1521/suli.2006.36.4.443 
[44] Beck, A.T., Steer, R.A., Kovacs, M., et al. (1985) Hope-
lessness and eventual suicide: A 10-year prospective study 
of patients hospitalized with suicidal ideation. American 
Journal of Psychiatry, 142, 559-563. 
[45] Isometsa, E. (2005) Suicide in bipolar I disorder in Fin- 
land: Psychological autopsy findings from the National 
Suicide Prevention Project in Finland. Archives of Suicide 
Research, 9, 251-260. doi:10.1080/13811110590929442 
[46] Palmer, B.A., Pankratz, S. and Bostwick, J.M. (2005) The 
lifetime suicide risk in schizophrenia. Archives of Gen-
eral Psychiatry, 62, 247-253. 
[47] Hawton, K. and James, A. (2005) Suicide and deliberate 
self-harm in young people. British Medical Journal, 330, 
891-894. doi:10.1136/bmj.330.7496.891 
[48] Murphy, G.E. (2002) Psychiatric aspects of suicidal be-
haviour: Substance abuse. In: Hawton K., van Heeringen 
K., Eds., The International Handbook of Suicide and At-
tempted Suicide, Wiley, Chichester. 
[49] Rossow, I. and Amundsen, A. (1995) Alcohol abuse and 
suicide: A forty year prospective study of Nerwegian 
conscripts. Addiction, 90, 685-691. 
doi:10.1111/j.1360-0443.1995.tb02206.x 
[50] Sher L. (2006) Alcoholism and suicidal behavior: A clini-
cal overview. Acta Psychiatrica Scandinavica, 113, 13-22. 
doi:10.1111/j.1600-0447.2005.00643.x 
[51] Gerson, J. and Stanley, B. (2002) Suicidal and self-in- 
jurious behaviour in personality disorder: Controversies 
and treatment directions. Current Psychiatry Reports, 4, 
30-38. doi:10.1007/s11920-002-0009-6 
[52] Isometsa, E.T. (2001) Psychological autopsy studies: A 
review. European Psychiatry, 16, 379-384. 
doi:10.1016/S0924-9338(01)00594-6 
[53] Schmidtke, A., Bille-Brahe, U., De-Leo, D., et al. (2004) 
Sociodemographic characteristics of suicide attempters in 
Europe: Combined results of the monitoring part of the 
WHO/EURO multicentre study on suicidal behaviour. In: 
Schmidtke, A., Bille-Brahe, U., De-Leo, D. and Ker- khof, 
A. Eds., Suicidal Behaviour in Europe: Results from the 
WHO/EURO Multicentre Study on Suicidal Behaviour. Ho- 
grefe & Huber, Göttingen, 29-43. 
[54] Krysinska, K., Heller, T.S. and De-Leo, D. (2006) Sui-
cide and deliberate self-harm in personality disorders. 
Current Opinion in Psychiatry, 19, 95-101. 
doi:10.1097/01.yco.0000191498.69281.5e 
[55] Kessler, R., Berglund, P., Demler, O., et al. (2005) Life-
time prevalence and age-of-onset distributions of DSM- 
IV disorders in the National Comorbidity Survey Repli-
cation. Archives of General Psychiatry, 62, 593-602.  
doi:10.1001/archpsyc.62.6.593 
[56] Hawgood, J., Spathonis, K. and De-Leo, D. (2004) Physi-
cal illness and suicidal behaviour. In: De-Leo, D., Bille- 
Brahe, U., Kerkhof, A.D.J.F. and Schmidtke, A., Eds., 
Suicidal Behaviour: Theories and Research Findings. 
Hogrefe and Huber, Göttingen, 139-164. 
[57] Madge, N., Hawton, K., McMahon, E., Corcoran, P., 
De-Leo, D., De Wilde, E.J., Fekete, S., Van Heeringen, 
C., Ystgaard, M. and Arensman, E. (2011) Psychological 
characteristics, stressful life events and deliberate-self- 
harm: Findings from the child and adolescent self-harm in 
Europe (CASE) study. European Child and Adolescent 
Psychiatry, 20, 499-508. doi:10.1007/s00787-011-0210-4 
[58] Scoliers, G., Portzky, G., Madge, N., Hewitt, A., Hawton, 
K., De Wilde, E.J., Ystgaard, M., Arensman, E., De-Leo, 
D., Fekete, S. and Van Heeringen, C. (2009) Reasons for 
adolescent deliberate self-harm: A cry of pain and/or a 
cry for help? Findings from the child and adolescent 
self-harm in Europe (CASE) study. Social Psychiatry and 
Psychiatry Epidemiology, 44, 601-607. 
doi:10.1007/s00127-008-0469-z 
[59] Mann, J.J., Apter, A., Bertolote, J., Beautrais, A., Currier, 
D., Haas, A., Hegerl, U., Lonnqvist, J., Malone, K., Ma-
rusic, A., Mehlum, L., Patton, G., Phillips, M., Rutz, W., 
Rihmer, Z., Schmidtke, A., Shaffer, D., Silverman, M., 
Takahashi, Y., Varnik, A., Wasserman, D., Yip, P. and 
Hendin, H. (2005) Suicide prevention strategies. A sys-
tematic review. Journal of the American Medical Asso-
ciation, 294, 2064-2074. doi:10.1001/jama.294.16.2064 
[60] De-Leo, D. and Diekstra, R.F.W. (1990) Depression and 
Suicide in Late Life. Hogrefe/Huber, Toronto/Bern. 
[61] Erlangsen, A., Nordentoft, M., Conwell, Y., Waern, M., 
De-Leo, D., Lindner, R., Oyama, H., Sakashita, T., An-
dersen-Ramberg, K., Quinnet, P., Draper, B., Lapierre, S. 
and the International Research Group on Suicide Among 
the Elderly (2011) Key considerations for preventing sui-
cide in older adults: Consensus opinions of an expert 
panel. Crisis, 32, 106-109. 
doi:10.1027/0227-5910/a000053 
[62] Hawton, K. and Harriss, L. (2006) Deliberate self-harm in 
people aged 60 years and over: Characteristics and out- 
come of a 20-year cohort. International Journal of Geri-
Copyright © 2012 SciRes.                                                                       OPEN ACCESS 
A. De Gioannis et al. / Open Journal of Psychiatry 2 (2012) 49-60 
Copyright © 2012 SciRes.                                                                      
60 
 OPEN ACCESS 
atric Psychiatry, 21, 572-581. doi:10.1002/gps.1526 
[63] De-Leo, D. and Scocco, P. (2000) Treatment and preven-
tion of suicidal behaviour in the elderly. In: Hawton, K. 
and Van Heeringen, K., Eds., The International Hand-
book of Suicide and Attempted Suicide, Wiley, Chichester, 
555-570. doi:10.1002/9780470698976.ch31 
[64] Gabbard, G.O. and Allison, S.E. (2006) Psychodynamic 
treatment. In: Simon, I. and Hales, R.E. Eds., Textbook of 
Suicide Assessment and Management. American Psychi-
atric Publishing, Washington DC, 221-234. 
[65] Simon, R.I. (2006) Patient safety versus freedom of move- 
ment: Coping with uncertainty, In: Simon, R.I. and Hales, 
R.E., Eds., Textbook of Suicide Assessment and Man-
agement. American Psychiatric Publishing, Washington 
DC, 423-439. 
[66] Bille-Brahe, U. and Jensen, B. (2004) The importance of 
social support. In: De-Leo, D., Bille-Brahe, U., Kerkhof, 
A.D.J.F. and Schmidtke A., Eds., Suicidal behaviour. The- 
ories and research findings, Hogrefe and Huber, Göttin-
gen, 197-208. 
[67] Fawcett, J., Busch, K.A. and Jacobs, D.G. (2003) Clinical 
correlates of inpatient suicide. Journal of Clinical Psy-
chiatry, 64, 14-19. doi:10.4088/JCP.v64n0105 
[68] Townsend, E., et al. (2001) The efficacy of problem- 
solving treatments after deliberate self-harm: Meta-ana- 
lysis of randomized controlled trials with respect to de-
pression, hopelessness and improvement in problems. 
Psychological Medicine, 31, 979-988. 
doi:10.1017/S0033291701004238 
[69] Brown, G.K., Ten Have, T.R., Henriques, G.R., et al. 
(2005) Cognitive therapy for the prevention of suicide at-
tempts: A randomized controlled trial. Journal of the 
American Medical Association, 294, 563-570.  
doi:10.1001/jama.294.5.563 
[70] Guthrie, E., Kapur, N., Mackway-Jones, K., et al. (2001) 
Randomised controlled trial of brief psychological inter-
vention after deliberate self poisoning. British Medical 
Journal, 323, 135-138. doi:10.1136/bmj.323.7305.135 
[71] Linehan, M.M., Comtois, K.A., Murray, A.M., Brown, 
M.Z., Gallop, R.J., Heard, H.L., Korslund, K.E., Tutek, 
D.A., Reynolds, S.K. and Lindenboim, N. (2007) Two- 
year randomized controlled trial and follow-up of dialec-
tical behaviour therapy by experts for suicide-related be-
haviours and borderline personality disorder. Archives of 
General Psychiatry, 63, 757-766.  
doi:10.1001/archpsyc.63.7.757 
[72] Bateman, A. and Fonagy, P. (2008) 8-year follow-up of 
patients treated for bosrderline personality disorder: Men- 
talisation-based treatment versus treatment as usual. Ame- 
rican Journal of Psychiatry, 165, 631-638. 
doi:10.1176/appi.ajp.2007.07040636 
[73] Crawford, M.J., Thomas, O., Khan, N. and Kulinskaya, E. 
(2007) Psychosocial interventions following self-harm: 
Systematic review of their efficacy in preventing suicide. 
British Journal of Psychiatry, 190, 11-17. 
doi:10.1192/bjp.bp.106.025437 
[74] Müller-Oerlinghausen, B., Felber, W., Berghöfer, A., Lau- 
terbach, E. and Ahrens, B. (2005) The impact of lithium 
long-term medication on suicide-related behaviours and 
mortality of bipolar patients. Archives of Suicide Research, 
9, 307-319. doi:10.1080/13811110590929550 
[75] Guzzetta, F., Tondo, L., Centorrino, F. and Baldessarini, 
R.J. (2007) Lithium treatment reduces suicide risk in re-
current major depressive disorder. Journal of Clinical 
Psychiatry, 68, 380-383. doi:10.4088/JCP.v68n0304 
[76] Young, A.H. and Hammond, J.M. (2007) Lithium in mood 
disorders: Increasing evidence base, declining use? Brit-
ish Journal of Psychiatry, 191, 474-476. 
doi:10.1192/bjp.bp.107.043133 
[77] Meltzer, H.Y., Alphs, L., Green, A.I., Altamura, A.C., 
Anand, R., Bertoldi, A., Bourgeois, M., Chouinard, G., 
Islam, M.Z., Kane, J., Krishnan, R., Lindenmayer, J.P. 
and Potkin, S. (2003) Clozapine treatment for suicidality 
in schizophrenia: International Suicide Prevention Trial 
Study Group (InterSePT). Archives of General Psychiatry, 
60, 82-91. doi:10.1001/archpsyc.60.1.82 
[78] Wahlbeck, K., Cheine, M. and Essali, M.A. (2000) Clo- 
zapine versus typical neuroleptic medication for schizo-
phrenia. Cochrane Database of Systematic Reviews, 2, 
CD000059.  
[79] Kellner, C.H., Fink, M., Knapp, R., et al. (2005) Relief of 
expressed suicidal intent by ECT: A consortium of re-
search in ECT study. American Journal of Psychiatry, 
162, 977-982. doi:10.1176/appi.ajp.162.5.977 
[80] Food and Drug Administration (2005) Reviews data for 
antidepressant use in adults.  
http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01
362.html  
[81] Dubicka, B., Hadley, S. and Roberts, C. (2006) Suicidal 
behaviour in youths with depression treated with new- 
generation antidepressants: Mata-analysis. British Jour-
nal of Psychiatry, 189, 393-398.  
doi:10.1192/bjp.bp.105.011833 
[82] Hammad, T.A., Laughren, T. and Racoosin, J. (2006) Sui- 
cidality in pediatric patients treated with antidepressant 
drugs. Archives of General Psychiatry, 63, 332-339.  
doi:10.1001/archpsyc.63.3.332 
[83] Bray, I. and Gunnell, D. (2006) Relationship between 
antidepressant sales and secular trends in suicide rates in 
the Nordic countries. British Journal of Psychiatry, 188, 
354-358. doi:10.1192/bjp.188.4.354 
[84] Zahl, P., De-Leo, D., Ekeberg, O., Hjelmeland, H. and 
Dieserud, G. (2010) The relationship between sales of 
SSRI, TCA and suicide rates in Nordic countries. BMC 
Psychiatry, 10, 1-9. 
[85] Gunnell, D., Saperia, J. and Ashby, D. (2005) Selective 
serotonin reuptake inhibitors (SSRIs) and suicide in adults: 
Meta-analysis of drug company data from placebo con-
trolled, randomised controlled trials submitted to the 
MHRA’s safety review. British Medical Journal, 19, 1-5. 
 
